Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Potential cellular and regenerative approaches for the treatment of Parkinson's disease

Lane, E. L. ORCID: https://orcid.org/0000-0001-8800-3764, Handley, O. J., Rosser, A. E. ORCID: https://orcid.org/0000-0002-4716-4753 and Dunnett, S. B. ORCID: https://orcid.org/0000-0003-1826-1578 2008. Potential cellular and regenerative approaches for the treatment of Parkinson's disease. Neuropsychiatric Disease and Treatment 4 (5) , pp. 835-845. 10.2147/NDT.S2013

[thumbnail of Lane 2008.pdf]
Preview
PDF - Published Version
Download (103kB) | Preview

Abstract

Parkinson’s disease is most commonly treated with a range of pharmacotherapeutics, with the more recent introduction of surgical techniques including deep-brain stimulation. These have limited capabilities to improve symptoms of the disease in more advanced stages, thus new therapeutic strategies including the use of viral vectors and stem cells are in development. Providing a continuous supply of dopamine to the striatum in an attempt to improve the treatment of motor symptoms using enzymes in the dopamine synthesis and machinery is one approach. Alternatively, there are tools which may serve to both protect and encourage outgrowth of surviving neurons using growth factors or to directly replace lost innervation by transplantation of primary tissue or stem cell-derived dopaminergic neurons. We summarize some of the potential therapeutic approaches and also consider the recent EU directives on practical aspects of handling viral vectors, cells and tissues, and in the running of clinical trials in Europe which impact on their development.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Neuroscience and Mental Health Research Institute (NMHRI)
Medicine
MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG)
Subjects: R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
Uncontrolled Keywords: transplantation, viral vector, stem cells, ethics, European Union directive
Additional Information: Pdf uploaded in accordance with publisher's policy at http://www.sherpa.ac.uk/romeo/issn/1176-6328/ (accessed 27/02/2014).
Publisher: Dove Medical Press
ISSN: 1176-6328
Date of First Compliant Deposit: 30 March 2016
Last Modified: 04 May 2023 03:33
URI: https://orca.cardiff.ac.uk/id/eprint/17619

Citation Data

Cited 14 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics